Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, has served as Principal Investigator for more than 700 clinical trials of metabolic therapeutic interventions and is one of the strongest scientific differentiators across the MBR network. He was Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center, Inc. (L-MARC), which was acquired by MBR in 2026. He is a nationally recognized investigator for obesity, endocrinology, lipid disorders, cardiometabolic disease, and MASH/MASLD research.
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Principal Investigator
Experience
- Board Certified in Internal Medicine, Endocrinology & Metabolism
- Diplomate, American Board of Obesity Medicine
- Diplomate, American Board of Clinical Lipidology
- 700+ trials conducted since 1986
- 350+ authored or co-authored scientific manuscripts and book chapters
- Chief Science Officer, Obesity Medicine Association; Editor-in-Chief, Obesity Pillars
- Diplomate, American Board of Obesity Medicine and American Board of Clinical Lipidology
Therapeutic Expertise
- Obesity
- Diabetes
- Cardiometabolic
- Lipids
- Migraines
- Fatty Liver (MASLD/NAFLD)
- Arthritis, Gout, Osteoporosis, and Pain
- Hypertension
Associated Site(s)
New at MBR
-
MBR Louisville Welcomes Shannon Bauman, MD as Principal Investigator
Please join us in welcoming Shannon Bauman, MD, CCFP, Dip. Sport Med to Monroe Biomedical Research (MBR)! Dr. Bauman is a Family Medicine and Sports & Exercise Medicine physician with nearly 20 years of clinical experience, now serving as a Principal Investigator at our Louisville, KY site. She brings a … Read more
-
MBR Louisville Welcomes Gerald Dryden, MD as Principal Investigator
Please join us in welcoming Gerald “Tad” Dryden, MD, PhD, MS, MSPH to Monroe Biomedical Research (MBR)! Dr. Dryden is a Professor of Medicine and board-certified gastroenterologist, now serving as a Principal Investigator at our Louisville, KY site. Dr. Dryden brings decades of academic medicine and clinical research experience to … Read more
-
MBR Welcomes Felicia Irvin as Chief Commercial Officer
We’re welcoming Felicia Irvin to MBR as Chief Commercial Officer. Felicia brings more than 15 years of experience in clinical research, with expertise spanning business development, operations, patient recruitment, and network growth. She has built her career by bridging commercial commitments with operational delivery. As CCO, she will lead MBR’s … Read more
